NPro Magnesio Sucrotec
Commercial- Indications
- Magnesium deficiency
Company intelligence / Profile preview
NPro offers a portfolio of commercialized dietary supplements targeting gastrointestinal health. Their products are formulated with combinations of plant extracts with antimicrobial properties, spore-forming probiotics for microbiota support, polyphenols for anti-inflammatory effects, and digestive aids. The company’s products are available online and through retail partners; no clinical trial data or regulatory drug development programs are reported in public sources. Their product line addresses common GI issues such as SIBO/IMO, candidiasis, parasitosis, IBS-C symptoms like constipation/bloating/pain/nausea/flatulence by supporting microbial balance and intestinal function.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NPro Salud Intestinal.